acquired
Stage
3
Investors
About
V-Wave develops a percutaneous implantable interatrial shunt device designed to reduce left atrial pressure by offloading blood volume from the left atrium to the right atrium, aimed at treating patients with chronic heart failure.
Explore V-Wave's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.